# HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/her2-exon-20-insertions-in-non-small-cell-lung-cancer-are-sensitive-to-the/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Y. Wang,Tao Jiang,Zhen Qin,Jinghui Jiang,Qiang Wang,Seung Hee Yang,Christopher J. Rivard,G. Gao,T L Ng,Megan M. Tu,Hui Yu,Huiping Ji,Caicun Zhou,Shengxiang Ren,Jun Zhang,Paul A. Bunn,Robert C. Doebele,D. Ross Camidge,Fred R. Hirsch |
| Citations | 217 |
| DOI | 10.1093/annonc/mdy542 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | http://www.annalsofoncology.org/article/S0923753419310774/pdf |
| OpenAlex ID | https://openalex.org/W2907907709 |
| PMID | 30596880 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Tao Jiang](https://scholariq.org/researchers/tao-jiang/)

## Paper journal

- [Annals of Oncology](https://scholariq.org/journals/annals-of-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Fibroblast Growth Factor Research](https://scholariq.org/topics/fibroblast-growth-factor-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.